Duke's Division of Pediatric Cardiology is a primary provider of cardiovascular diagnostic and treatment services in the southeastern United States. Our dedication to care and treatment of people of all ages, along with an emphasis on cutting-edge research, results in a program that is among the best in the country.

The faculty offer a comprehensive spectrum of clinical services to treat cardiovascular diseases that may affect the fetus, infant, child, adolescent, or young adult. Our research programs also include a number of clinical trials conducted through the NIH-funded Pediatric Heart Network, as well as several industry-sponsored clinical trials in congenital heart disease.

Duke Heart Services

• Over 700 faculty and staff members with over 100 board-certified cardiologists, cardiac surgeons, and cardiac anesthesiologists
• One of the world’s leading cardiovascular clinical research programs, including the Duke Clinical Research Institute and Duke Databank for Cardiovascular Disease -- the largest and oldest database of coronary artery disease outcomes
• Serving as the analytic engine for the American College of Cardiology’s National Cardiovascular Data Registry, the Society of Thoracic Surgeons’s National Database, the CRUSADE National Quality Improvement Initiative, and the American Heart Association’s Get with the Guidelines initiative
• Top congestive heart failure program in the country (based on volume, NIH and private funding, and publications)
• First and longest-running post-CABG cardiac rehabilitation practice in the country
• Largest cardiovascular MRI program in the world (based on clinical volume and research funding)
• Largest cardiac transplant, congestive heart failure, adult valvular, and congenital heart disease programs in the Southeast
• Consistently ranked among the top heart programs in the nation by U.S.News & World Report
• Home to major breakthroughs in cardiovascular care, including the first perfusion balloon angioplasty catheter, first realtime volumetric ultrasound system for 3-D heart imaging, and introduction of the bioabsorbable coronary stent